منابع مشابه
New Hypoglycemic Agents Require Perioperative Precautions New Hypoglycemic Agents: A Special Presentation
Background: New noninsulin hypoglycemic agents, the incretin and amylin groups, are available to treat patients with type 2 diabetes and inadequate glucose control with the regular routinely used agents, namely metformin or sulfonylurea. Incretin therapies are based on the release of intestinal peptides (glucagon-like peptide 1) in the presence of glucose in the gut which stimulates insulin sec...
متن کاملThe use of oral hypoglycemic agents.
This DESG Teaching Letter was written by the DESG Executive commitee: Executive commitee: Dr. J.M. BOAVIDA, MD, Lisbon – Portugal (President); Dr. A. BROOKS, MD, Winchester – UK (Vice-President); Dr. I. HARMAN-BOEHM, MD, Sheva – Israel. (Director Educational Strategies); Ms. D. VARAKLA, Athens – Greece (Honorary Secretary); Dr. A. BALDELLI, MD, Rome – Italy (Honorary Treasurer); Dr. R. CHLUP, M...
متن کاملHypoglycemic agents and potential anti-inflammatory activity.
Current literature shows an association of diabetes and secondary complications with chronic inflammation. Evidence of these immunological changes include altered levels of cytokines and chemokines, changes in the numbers and activation states of various leukocyte populations, apoptosis, and fibrosis during diabetes. Therefore, treatment of diabetes and its complications may include pharmacolog...
متن کاملAdherence to Oral Hypoglycemic Agents in Hawaii
INTRODUCTION Adherence to oral hypoglycemic agents is essential to reducing the poor health outcomes of populations at high risk for developing diabetes and its chronic complications. The goal of this study was to identify characteristics of patients in Hawaii least likely to adhere to oral hypoglycemic agents. METHODS This retrospective administrative data analysis included prescription refi...
متن کاملOral Hypoglycemic Agents in pregnancy: An Update.
INTRODUCTION Traditionally, insulin has been the gold standard in the management of Type 2 diabetes in pregnancy and gestational diabetes. However, insulin therapy can be inconvenient because of the needs for multiple injections, its associated cost, pain at the injection site, need for refrigeration, and skillful handling of the syringes. This has led to the exploration of oral hypoglycemic ag...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: YAKUGAKU ZASSHI
سال: 1964
ISSN: 0031-6903,1347-5231
DOI: 10.1248/yakushi1947.84.10_1021